-
SR 11302 for AP-1 Cancer Workflows
2026-08-13
SR 11302 provides a receptor-sparing way to interrogate AP-1-driven proliferation, tumor promotion, and immune–tumor interactions. This workflow-oriented guide connects cancer-cell assays with macrophage-polarization models while emphasizing formulation control, assay selection, and interpretation limits.
-
SCH772984 HCl: ERK1/2 Inhibitor Workflow
2026-08-13
Use SCH772984 HCl to validate ERK-dependent signaling, model resistance in BRAF- and RAS-mutant systems, and connect acute pathway inhibition with longer-term TERT and telomerase assays. This practical guide covers dosing design, orthogonal readouts, assay controls, and troubleshooting without treating an emerging stem-cell connection as established causality.
-
Deferasirox Fe3+ Chelate in Iron-Stress Assays
2026-08-12
Use Deferasirox Fe3+ chelate as a defined ferric-complex tool for separating iron handling from glucose-starvation, lysosomal, and cell-death phenotypes. Its organic-solvent solubility and compatibility with staged concentration and starvation workflows support reproducible iron overload treatment research without implying clinical efficacy.
-
Lisinopril dihydrate ACE Inhibitor Workflows
2026-08-11
Lisinopril dihydrate supports controlled ACE inhibition across enzyme, cell, tissue, and disease-relevant models. This guide translates its 4.7 nM reported IC50, water-compatible handling, and peptidase selectivity considerations into practical workflows for cardiovascular and renal research.
-
Haloprogin: From MIC Data to Model Design
2026-08-11
Haloprogin is a topical antimicrobial research compound with activity against dermatophytes, Candida, and selected Gram-positive bacteria. This article explains how to translate its MIC, MFC, formulation, and infection-model evidence into better assay decisions.
-
Bone-Penetrating Nanoassembly for Cuproptosis
2026-08-10
The reference study introduces BCB, a baicalein–copper coordinated nanoassembly integrated with a boron-dipyrromethene photosensitizer to combine chemodynamic therapy, photodynamic therapy, and copper-dependent cell death. Its reported bone penetration, tumor-microenvironment responsiveness, glutathione depletion, and 75% cure rate in a murine melanoma model illustrate how coordinated ROS generation may address both primary and bone-associated tumors.
-
Trichostatin A: A Smarter Epigenetic Assay Strategy
2026-08-09
Trichostatin A (TSA) is more than a broad HDAC inhibitor: it can serve as a reversible perturbation tool for connecting histone acetylation with phenotype. This guide translates recent causal-assay principles into practical cancer research workflows while clarifying TSA’s limitations and experimental boundaries.
-
PP 2 (AG 1879) for Reliable Cell Assays
2026-08-08
Learn how PP 2 (AG 1879), SKU A8216, can support mechanistic studies of cell proliferation, cytotoxicity, immune signaling, and vascular responses. This scenario-based guide covers selectivity, solvent handling, dose interpretation, and practical vendor-selection criteria.
-
Oteseconazole (VT-1161) Research Workflows
2026-08-07
Oteseconazole (VT-1161) combines potent Candida CYP51 inhibition with comparatively low human CYP3A4 inhibition, making it useful for susceptibility, resistance, and translational selectivity studies. This workflow-focused guide covers dosing, controls, strain selection, troubleshooting, and how recent tetrazole research can improve assay design.
-
GW4064: Non-Steroidal FXR Agonist for Precision Metabolic Re
2026-08-07
GW4064, a potent non-steroidal FXR agonist from APExBIO, enables researchers to dissect bile acid, cholesterol, and triglyceride regulation with unmatched selectivity. This guide translates cutting-edge insights into actionable protocols, troubleshooting tips, and comparative workflows to accelerate metabolic research.
-
TaqI Restriction Endonuclease: Rapid, Reliable DNA Digestion
2026-08-06
TaqI Restriction Endonuclease (SKU K3053) provides a high-efficiency solution for researchers requiring fast, sequence-specific digestion of plasmid, PCR, or genomic DNA. It addresses bottlenecks in time-sensitive molecular biology workflows and is suitable for research use only, not for diagnostic or medical applications.
-
Acridine Orange hydrochloride: Technical Guide for Nucleic A
2026-08-06
Acridine Orange hydrochloride enables rapid, differential fluorescent staining of DNA and RNA in live or fixed cells, facilitating workflows such as cell cycle analysis and apoptosis detection. It is not suitable for applications outside nucleic acid-specific fluorescence or for workflows requiring long-term solution stability.
-
PERK–JAK1–STAT3 Axis Drives Pyroptosis in Disc Degeneration
2026-08-05
This study elucidates how endoplasmic reticulum stress aggravates nucleus pulposus cell pyroptosis via PERK-dependent JAK1–STAT3 signaling, clarifying a crucial pathway in intervertebral disc degeneration. These findings uncover new molecular targets to mitigate pyroptosis-driven inflammation and potentially slow disc degeneration progression.
-
DMH-1: Elevating Organoid & NSCLC Research with ALK2 Precisi
2026-08-05
This thought-leadership article explores DMH-1's mechanistic impact as a selective ALK2 inhibitor, bridging advanced pancreatic organoid generation and non-small cell lung cancer research. Grounded in the latest peer-reviewed protocols and strategic guidance, the piece addresses biological rationale, experimental best practices, translational potential, and forward-looking implications for disease modeling and therapeutic discovery.
-
LY364947: A Precision TGF-β Type I Receptor Kinase Inhibitor
2026-08-04
LY364947 stands out as a selective, high-potency TGF-β type I receptor kinase inhibitor, enabling rigorous modulation of EMT, fibrosis, and retinal degeneration models. This article breaks down best-practice workflows, advanced troubleshooting, and actionable insights to maximize reproducibility and experimental impact with APExBIO’s LY364947.
449 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page